Michael Mack, M.D.
April 11th, 2011
PARTNER A: An Investigator’s View
Michael Mack, M.D.
CardioExchange welcomes Dr. Michael Mack to discuss the results of the PARTNER study of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (AVR) in patients with aortic stenosis, which were just released at the ACC meetings in New Orleans. Dr. Mack was one of the principal investigators in this and the recently published […]
September 23rd, 2010
Howdy, PARTNER!
Michael Mack, M.D., E Murat Tuzcu, MD, L. David Hillis, MD and Richard A. Lange, MD, MBA
CardioExchange welcomes Mike Mack and E. Murat Tuzcu, investigators for the PARTNER trial, an ongoing, randomized study of transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis at high surgical risk. The first reported findings, published in the New England Journal of Medicine, showed an impressive 20% absolute reduction in 12-month mortality with […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy